Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.
This study has been withdrawn prior to enrollment.
Information provided by:
First received: September 9, 2005
Last updated: March 19, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||No date given|